The 12 closest competitors and alternatives to ElevateBio among biotech companies — ranked by similarity to what ElevateBio actually does, not by market-cap band.
Subscribe to see ElevateBio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ElevateBio is a biotechnology company that builds and operates cell and gene therapy companies and provides development, manufacturing, and technology capabilities through its platform, including BaseCamp. It serves biotech and pharmaceutical organizations developing advanced therapies, as well as supporting the creation of new therapeutic companies.
ElevateBio is a biotech company headquartered in United States. Xcout recorded 41 job postings from ElevateBio in the last 90 days, naming tools such as SAP.
Xcout recorded 41 job postings from ElevateBio in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see ElevateBio's hiring signals →
Ranked by semantic similarity — how close each company is to ElevateBio by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotech company
AGC Biologics is a global contract development and manufacturing organization (CDMO) that provides services for protein-based biologics and advanced therapies, including mammalian and microbial production, viral vectors, cell therapy, plasmid DNA, and mRNA. The company supports biopharmaceutical developers by offering process development, analytical formulation, cGMP manufacturing, and fill-finish services to help bring life-changing treatments to market.
Similar biotech company
Forge Biologics Holdings, LLC is the parent company of Forge Biologics, a U.S.-based contract development and manufacturing organization focused on gene therapies, particularly adeno-associated virus (AAV) programs. It provides process development, analytical services, and clinical and commercial manufacturing to biotechnology and pharmaceutical companies.
Biotechnology
Arranta Bio is a biotechnology contract development and manufacturing organization (CDMO) focused on microbiome-based therapeutics, including live biotherapeutic products. It serves biopharmaceutical companies with process development, analytical, and manufacturing services for these products.
Life Sciences
Cirsium Biosciences is a San Diego-based biotech company focused on democratizing gene therapy. The company is redefining AAV production through transformative viral vector production methods and systems.
Similar biotech company
Samsung Biologics operates as a global contract development and manufacturing organization (CDMO) providing end-to-end biopharmaceutical services to pharmaceutical and biotech companies. The company offers a range of services including cell line development, process development, analytical testing, drug substance and drug product manufacturing, and advanced modalities like bioconjugation and mRNA.
Biotechnology
Aloft Biotechnologies is a biotechnology company that develops microgravity biomanufacturing technology for space and terrestrial applications. The company provides cell processing, microbial culture, and fluid management systems designed for medical innovation and drug manufacturing in Low Earth Orbit.
Similar biotech company
Just-Evotec Biologics is a Seattle-based subsidiary of Evotec SE focused on innovative biologics drug discovery and manufacturing. Operating research and production facilities such as J.POD in Washington State, the company develops technologies for global access to biotherapeutics. It partners with major philanthropic organizations like the Gates Foundation to advance global health.
Similar biotech company
Landmark Bio is an Artis BioSolutions biotechnology research company headquartered in Watertown, Massachusetts. It is dedicated to accelerating the translation and development of next-generation advanced genetic medicines.
Similar biotech company
Oxford Biomedica plc is a biopharmaceutical firm focused on the discovery, advancement, and sophisticated bioprocessing of innovative cell and gene therapies. Operating globally, with a strong presence across Europe, the company organizes its activities into two segments: Platform and Product. Its proprietary LentiVector platform technology facilitates the integration of genes into non-dividing cells, such as neurological cells in the brain and retinal cells in the eye, and can incorporate diverse therapeutic genes. The company's developmental pipeline includes promising candidates like Axo-Lenti-PD, a gene-based treatment for Parkinson's disease. Other pre-clinical stage programs feature OXB-302, targeting haematological tumors, and OXB-401, OXB-40X, and OXB-40Y, all addressing liver indications. Oxford Biomedica maintains numerous strategic alliances with prominent pharmaceutical entities such as Novartis, Bristol Myers Squibb, Sio Gene Therapies, Orchard Therapeutics, Boehringer Ingelheim, the UK Cystic Fibrosis Gene Therapy Consortium, Immatics, Arcellx, and the Vaccines Manufacturing and Innovation Centre. Additionally, it engages in research collaborations, including a partnership with Circularis Biotechnologies to identify novel tissue-specific promoters for in vivo lentiviral gene therapy, Virica Biotech for scaling viral medicines, Isolere Bio for enhancing downstream manufacturing efficiencies of biologics, and BiologIC Technologies for utilizing a novel biocomputer system in viral vector development. Founded in 1995, Oxford Biomedica plc is headquartered in Oxford, United Kingdom.
Similar biotech company
Established in 1995 and headquartered in Tokyo, Japan, MEDINET Co., Ltd. functions as a contract development and manufacturing organization (CDMO) primarily focused on regenerative medicine and cell therapy solutions within Japan. The company furnishes comprehensive support for immuno-cell therapy, encompassing critical elements such as specialized technical expertise, advanced facilities, robust operational systems, essential materials, and skilled cell engineers. Furthermore, MEDINET actively manufactures regenerative medical products, investigational cell products, and other specified cell-based therapies. Its extensive value chain offerings also cover personnel training, facility and equipment design, operational management, standard operating procedure (SOP) preparation, logistics networks, information systems, purchasing and production management, stringent quality management and assurance, and technology transfer and process development. The firm actively collaborates with and supports medical institutions, research organizations, and biopharmaceutical companies in their endeavors to advance immuno-cell therapy.
Biotechnology
Saku Biosciences is an early-stage life sciences company founded in 2024 to improve the economics of biomanufacturing. The firm develops high-performance host cell products designed to advance biological manufacturing processes and therapeutic production. It operates out of Los Angeles, California, with a small team of approximately 8 employees.
Similar biotech company
Pharmicell develops and provides stem cell therapeutics, cell culture media, and biomedical products, alongside chemical raw materials and advanced industrial materials such as nucleosides and medical PEGs. The company serves patients, researchers, and medical institutions by offering stem cell-based treatments, contract development and manufacturing (CDMO) services, and stem cell-derived cosmetics.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for ElevateBioand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →